Brief: Anixa Biosciences Submits Protocol Amendment For Car-T Trial
30/09/2024 13:55
Sept 30 (Reuters) - Anixa Biosciences Inc ANIX.O :
* ANIXA BIOSCIENCES ANNOUNCES SUBMISSION OF PROTOCOL
AMENDMENT FOR
CAR-T TRIAL
* ANIXA BIOSCIENCES INC - AMENDMENT WILL ALLOW A SECOND DOSE
OF
CAR-T THERAPY TO SUITABLE PATIENTS
Source text for Eikon: urn:newsml:reuters.com:*:nPn5CG8Vma
Further company coverage: ANIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anixa Biosciences
See all newsBrief: Anixa Biosciences Announces First Case Of Stable Disease For Three Months In Ovarian Cancer Car-T Clinical Trial
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Anixa Biosciences Inc reports results for the quarter ended July 31 - Earnings Summary
Anixa Biosciences Inc expected to post a loss of 9 cents a share - Earnings Preview
Factbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine